Medicare Enrolled
Dr. Premranjan Singh, MD
Internal Medicine · Ocala, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Singh
Dr. Premranjan Singh is an internal medicine specialist in Ocala, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 12,913 Medicare services across 5,113 unique beneficiaries.
Between the years covered by Open Payments, Dr. Singh received a total of $25,051 from 51 pharmaceutical and/or device companies across 627 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 2% volume in FL
$25,051 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 104180 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗12,913
Medicare services
Top 2% in FL for internal medicine
5,113
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~717 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 4,605 | $0 | $0 |
| Office visit, established patient (30-39 min) | 1,653 | $91 | $234 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,040 | $44 | $108 |
| Electrocardiogram (EKG), 12-lead | 660 | $10 | $36 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 444 | $315 | $800 |
| Echocardiogram, transthoracic | 308 | $140 | $393 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 274 | $53 | $142 |
| Office visit, established patient (20-29 min) | 244 | $61 | $159 |
| Remote pacemaker/defibrillator monitoring, 90 days | 235 | $15 | $49 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 222 | $2,089 | $4,831 |
| Nuclear medicine study of heart muscle blood flow by pet | 222 | $140 | $342 |
| Prothrombin time test (blood clotting) | 214 | $4 | $11 |
| Anticoagulant management of patient taking warfarin | 204 | $8 | $24 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 201 | $28 | $71 |
| Initial hospital admission, moderate complexity | 195 | $104 | $277 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 176 | $9 | $22 |
| Hospital follow-up visit, moderate complexity | 157 | $63 | $149 |
| Remote pacemaker monitoring, 90 days | 144 | $21 | $61 |
| New patient office visit (45-59 min) | 129 | $109 | $333 |
| Injection, midazolam hydrochloride, per 1 mg | 125 | $0 | $1 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 120 | $20 | $57 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 106 | $47 | $161 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 104 | $167 | $215 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 92 | $24 | $100 |
| Programming of dual lead pacemaker system | 89 | $58 | $142 |
| Ultrasound of leg arteries or artery grafts | 85 | $174 | $481 |
| Hospital follow-up visit, low complexity | 85 | $40 | $81 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 82 | $20 | $55 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 73 | $135 | $392 |
| Cardiac catheterization | 71 | $232 | $613 |
| Ultrasound of both sides of head and neck blood flow | 69 | $136 | $387 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 57 | $39 | $101 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 52 | $325 | $935 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 45 | $85 | $242 |
| Review by radiologist of abdominal aorta image | 37 | $98 | $278 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 35 | $828 | $2,711 |
| Ultrasound of heart, follow-up | 32 | $66 | $193 |
| Coronary stent placement | 29 | $483 | $1,286 |
| Review by radiologist of arm or leg artery image | 27 | $119 | $331 |
| Removal of plaque in arteries of leg | 23 | $6,559 | $17,693 |
| Programming of multiple lead implantable defibrillator system | 18 | $82 | $197 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 16 | $20 | $53 |
| Programming of dual lead implantable defibrillator system | 15 | $74 | $181 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $83 | $214 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $14 | $36 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $2 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $11 | $30 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 14 | $67 | $204 |
| Balloon dilation of artery of leg, initial vessel | 13 | $2,214 | $8,979 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $303 | $785 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.0% high complexity
53.5% medium
38.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,051
Total received (2018-2024)
Avg $3,579/year across 7 years
Top 3% in FL for internal medicine
51
Companies
627
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,899 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$152 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,083
2023
$4,015
2022
$2,728
2021
$4,787
2020
$577
2019
$6,229
2018
$3,632
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Penumbra, Inc.
$4,730
Boston Scientific Corporation
$1,999
Medtronic Vascular, Inc.
$1,440
Amgen Inc.
$1,258
Janssen Pharmaceuticals, Inc
$1,242
Abbott Laboratories
$1,234
AngioDynamics, Inc.
$1,166
ABIOMED
$1,049
Boehringer Ingelheim Pharmaceuticals, Inc.
$942
PFIZER INC.
$882
AstraZeneca Pharmaceuticals LP
$766
Medtronic, Inc.
$761
Edwards Lifesciences Corporation
$705
ShockWave Medical, Inc
$594
Novartis Pharmaceuticals Corporation
$438
United Therapeutics Corporation
$406
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$395
Merck Sharp & Dohme LLC
$393
E.R. Squibb & Sons, L.L.C.
$367
Impulse Dynamics (USA) Inc.
$364
SANOFI-AVENTIS U.S. LLC
$352
LimFlow Inc.
$330
Teleflex LLC
$319
Cardiovascular Systems Inc.
$275
Shockwave Medical, Inc
$270
BOSTON SCIENTIFIC CORPORATION
$266
Astellas Pharma US Inc
$218
Lexicon Pharmaceuticals, Inc.
$196
BIOTRONIK INC.
$192
Cook Medical LLC
$167
Stryker Corporation
$125
Amarin Pharma Inc.
$120
Regeneron Healthcare Solutions, Inc.
$115
Bayer HealthCare Pharmaceuticals Inc.
$91
ARBOR PHARMACEUTICALS, INC.
$87
ATRICURE, INC.
$83
Philips Electronics North America Corporation
$81
Kestra Medical Technology Services, Inc.
$78
Merck Sharp & Dohme Corporation
$77
Braemar Manufacturing, LLC
$75
Lundbeck LLC
$72
Aziyo Biologics, Inc.
$68
Esperion Therapeutics, Inc.
$56
Inari Medical, Inc.
$49
Bardy Diagnostics, Inc.
$42
Gilead Sciences, Inc.
$32
Philips North America LLC
$26
Alnylam Pharmaceuticals Inc.
$22
Allergan Inc.
$19
EKOS Corporation
$11
CashFlow Solutions, LLC
$11
Top 3 companies account for 32.6% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (5091) Amb Mon & Diag Und · (7999) SRC Undivided · (CM9) Amb Mon & Diag Und · 3F · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · AURYON LASER SYSTEM 100-120 VAC · AVEIR · AVVIGO Guidance System · Adempas · Advisa · Armada 35 percutaneous catheter · Assure WCD · Auryon Laser System 100-120 Vac · BRILINTA · BYSTOLIC · Bidil · CAMZYOS · COOK MEDICAL CATHETERS · COOK MEDICAL ZILVER PTX · COREVALVE EVOLUT R · CRESEMBA · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Claria MRI · ClosureFast · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DYNAGEN MINI ICD VR · ECM Patch · EKOSONIC · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Edarbi · Edarbyclor · Edora · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipsys · Endurant · FARXIGA · FLOWTRIEVER CATHETER · GENERAL THERAPIES · GENERAL THERAPIES · HawkOne · IGT D Peripheral · IN.PACT Admiral · INGEVITY · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · JETI PERIPHERAL CATHETER · JOT DX · Kerendia · LEQVIO · LEXISCAN · LIMFLOW SYSTEM · LINQ II · LUX-DX · LYMPHA PRESS OPTIMAL PLUS(US) BT · LifeVest · MAKO · MANTA · MITRACLIP · MULTAQ · NEXLETOL · NONE · NORTHERA · No Associated Product · ONPATTRO · ORENITRAM · Optimizer · Optimizer Smart System · Optis Coronary Imaging System · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRO-Kinetic Energy · Penumbra System · Peripheral Orbital Atherectomy System · Pouch · Repatha · Resolute · Reveal LINQ · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SQRX PULSE GENERATOR · SYMPLICITY G3 · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TYVASO · VERQUVO · VYNDAMAX · VYNDAQEL · Valve Repair Flexible Rings and Bands · Varithena Administration Pack · Vascepa · Vascular Lithotripsy · VenaSeal · WATCHMAN · WATCHMAN FLX · XARELTO · XIENCE SKYPOINT · Zero Gravity · Zilver PTX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for internal medicine in FL.
Equivalent to $194 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
245
Per 100K population
63.2
County median income
$58,535
Nearest hospital
ADVENTHEALTH OCALA
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Singh is a clinical cardiology specialist, with above-average Medicare volume (top 2% in FL), with low-engagement industry engagement in the top 3% of FL peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Singh experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Singh performed 4,605 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $25,051 from 51 companies across 627 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other internal medicine physicians in Ocala?
Dr. Singh's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Ocala
Browse internal medicine physicians in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in FL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in FL
Which FL internal medicine physicians receive the most from drug and device companies.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology